Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions

情绪反应性和调节对乳腺癌治疗决策的影响

• 批准号: 9146318
• 负责人: Amit Etkin
• 金额: $ 62.34万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2015
• 资助国家: 美国
• 起止时间: 2015-09-18 至 2020-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9146318
• 关键词: Affect; Affective; Affective Symptoms; Age; Anxiety; Awareness; Bilateral; Biometry; Breast Cancer Patient; Breast Cancer Treatment; Clinical; Conscious; Control Groups; Data; Decision Making; Diagnosis; Distress; Emotional; Emotions; Functional Magnetic Resonance Imaging; Future; Group Psychotherapy; Health; Hydrocortisone; Influentials; Intervention; Magnetic Resonance; Malignant Neoplasms; Mastectomy; Measures; Medical; Mental Depression; Metastatic breast cancer; Neurobiology; Operative Surgical Procedures; Patient Self-Report; Patients; Personal Satisfaction; Physiological; Principal Investigator; Publishing; Race; Recruitment Activity; Recurrence; Regulation; Risk Reduction; Salivary; Sampling; Stimulus; Surgical complication; Woman; affective neuroscience; alternative treatment; anxious; base; biological adaptation to stress; breast cancer diagnosis; cancer risk; cost; depressed patient; emotion regulation; experience; follow-up; functional status; malignant breast neoplasm; negative affect; oncology; programs; psychosocial; tumor progression

 DESCRIPTION (provided by applicant): Women diagnosed with breast cancer are choosing bilateral mastectomy (BLM) at increasing rates, currently 14.3%, and 33% of those under 40. This is happening despite evidence that there is no survival benefit from BLM, along with surgical complications and other serious medical and personal costs, compared with more conservative approaches. Women's anxiety about recurrence is critical to this decision, so their choice may in large part reflect the way they experience and regulate affect. To understand the neurobiological and affective determinants of the choice of BLM, and thereby identify future opportunities for new interventions, we propose to examine the relationship between affect reactivity and regulation and women's decisions regarding BLM after initial diagnosis of breast cancer. We will also examine the impact of affect management and treatment decisions on subsequent psychosocial functioning. The study will involve recruiting a sample of 150 women recently diagnosed with breast cancer after their decision about treatment (75 who have elected BLM and 75 demographically and medically similar women who have decided not to have BLM), as well as a matched control group of 50 women without breast cancer. Affective reactivity to negative non-cancer and cancer- related stimuli will be studied using functional magnetic resonance imagining (fMRI). Likewise, affective regulation will be assessed with fMRI probes of both explicit (i.e. conscious, deliberate) and implicit (i.e. nonconscious, automatic) regulation o negative non-cancer and cancer-related stimuli. Psychosocial functioning will be assessed using self-report measures of anxiety, depression, well-being and functional status at 6, 12, and 18 months post-decision. Informational (e.g. awareness of influential people who have undergone BLM), and demographic variables (age, race, SES) will also be assessed. A physiological stress response measure, diurnal salivary cortisol slope, will be obtained at baseline and all follow-ups. This measure has been shown be associated with expression of negative affect, and to predict breast cancer progression. Our Specific Aims are to: 1) Examine affect reactivity and regulation among women with a recent diagnosis of breast cancer in comparison to healthy controls; 2) Relate affect reactivity and regulation to choice of BLM; and 3) Assess long term functional consequences of BLM decision and affect reactivity and regulation. This study will provide an empirical basis for better assisting patients in making difficult but important choices regarding breast cancer treatment alternatives.

 描述(申请人提供)：确诊为乳腺癌的女性选择双侧乳房切除术(BLM)的比例正在上升，目前为14.3%，40岁以下的女性中有33%。尽管有证据表明，与更保守的方法相比，BLM没有生存益处，以及手术并发症和其他严重的医疗和个人成本，但这种情况仍在发生。女性对复发的焦虑对这一决定至关重要，因此她们的选择在很大程度上可能反映了她们体验和调节情感的方式。为了了解选择BLM的神经生物学和情感决定因素，从而确定未来新干预的机会，我们建议研究情感反应性和调节与女性在乳腺癌初步诊断后关于BLM的决定之间的关系。我们还将研究情感管理和治疗决定对随后的心理社会功能的影响。这项研究将招募150名最近在决定治疗后被诊断为乳腺癌的女性样本(75名选择了BLM，75名在人口统计学和医学上相似的女性决定不接受BLM)，以及50名没有乳腺癌的女性作为匹配的对照组。对非癌症和癌症相关的负性刺激的情感反应将使用功能磁共振成像(FMRI)进行研究。同样，情感调节将通过fMRI探头对非癌症和癌症相关的负性刺激进行显性(即有意识的、有意的)和隐性(即无意识的、自动的)调节来评估。在决定后6个月、12个月和18个月，将使用焦虑、抑郁、幸福感和功能状态的自我报告测量来评估心理社会功能。还将评估信息(例如，对经历过BLM的有影响力的人的认识)和人口统计变量(年龄、种族、社会经济地位)。生理应激反应测量，每日唾液皮质醇斜率，将在基线和所有随访中获得。 这一指标已被证明与负面情绪的表达有关，并可预测乳腺癌的进展。我们的具体目标是：1)与健康对照组相比，检查最近诊断为乳腺癌的女性的情感反应性和调节；2)将情感反应性和调节与BLM的选择联系起来；以及3)评估BLM决定的长期功能后果，并影响反应性和调节。这项研究将为更好地帮助患者在乳腺癌治疗方案方面做出困难但重要的选择提供经验基础。